|
A novel pancreas-directed local approach, using image-guided nanoembolization, increases intra-tumoral uptake of therapeutic gold nanoparticles over systemic IV administration in a rabbit model of pancreatic ductal adenocarcinoma (PDAC), according to a presentation at the Society of Interventional Radiology's (SIR) 35th annual scientific meeting in Tampa, Fla. this week.
Iin an effort to treat Glioblastoma multiforme, researchers have used a combination of radiotherapy and the clinically approved drug AMD3100--a small molecule inhibitor-- to successfully block a secondary tumor-growth process in laboratory mice, according to an article published online Feb. 22 in the Journal of Clinical Investigation.
Researchers at George Mason University in Fairfax, Va., have started a three-year clinical trial in partnership with investigators at Inova health system and Fairfax Northern Virginia Hematology Oncology research program to treat late-stage colorectal cancer patients based on the protein makeup of their tumors.
Vital Images highlighted the new clinical enhancements to its Vitrea Enterprise Suite at the annual meeting of the Radiological Society of North America in Chicago last week.
The ProCure Proton Therapy Center in Oklahoma City has opened its second treatment room, allowing for the expansion of the number of patients, as well as the types of tumors that the center can treat.
Written by Lisa Fratt
CHICAGO--Molecular imaging is here to stay, posed David Gilmore, MS, CNMT, program of director nuclear medicine at Beth Israel Deaconess Medical Center in Boston. Yet, molecular imaging continues to evolve and impact the technologist. Gilmore peered into the crystal ball to help techs better understand the coming molecular imaging revolution and its impact on them during a Tuesday morning educational session at the annual 2009 Radiological Society of North America (RSNA) meeting.
BOSTON--Novel targeted cancer therapies could benefit from nuclear MR (NMR) and spectroscopy imaging to obtain an early indication of drug efficacy and guide personalized medicine, according to a presentation Tuesday at the Molecular Targets and Cancer Therapeutics (MTCT) conference.
Biennial mammography screening of average risk women between the ages of 50 and 74 accomplishes most of the benefits of annual screening with less risk of false-positive mammograms, unnecessary biopsies and over-diagnosis, according to a study by researchers from the Cancer Intervention and Surveillance Modeling Network published in the November edition of the Annals of Internal Medicine.
Human embryonic stem cells could be used to help restore cognitive abilities in patients after radiation for brain tumors, according to study appearing online Nov. 9 in the Proceedings of the National Academy of Sciences.
A study performed by researchers from University Hospitals Case Medical Center in Cleveland found that the use of MR spectroscopy, followed by Elekta's Gamma Knife radiosurgery (accompanied with conventional radiotherapy) in treating glioblastoma multiforme increases patients’ survival rates by 3.7 months compared with patients treated with conventional radiotherapy alone.
|
A new technique called personalized analysis of rearranged ends provides an accurate and specific way to monitor tumors by identifying personalized biomarkers from tumor DNA, according to a study published in the Feb. 24 issue of Science Translational Medicine.
Through a collaborative effort by the American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR), practice guidelines for image guided radiation therapy and stereotactic body radiation therapy have been created and released to assist practitioners in providing appropriate radiologic care for patients.
A study published in the December issue of Clinical Nuclear Medicine found that PET/CT with F18-FDOPA is superior to both F18-FLT and F18-FDG for visualization of primary and recurrent low-grade gliomas.
Research published in the December issue of the American Journal of Surgery has determined that 18F-FDG PET/CT imaging using becquerel has the potential to discern malignant lesions from benign tissues within both in vivo and ex vivo scans.
Knottin peptides may be a promising platform for designing novel contrast agents for molecular ultrasound imaging of tumor angiogenesis, according to a study presented at the annual Radiological Society of North America (RSNA) meeting.
PET strategies are very useful in monitoring the distribution and kinetics of vector-mediated gene expression, as well as the response to therapy in malignant glioma, according to a presentation last week at the Molecular Targets and Cancer Therapeutics (MTCT) conference in Boston.
The use of PET/CT after a patient completes chemoradiotherapy for head and neck cancer could help identify whether that patient will respond to treatment or will require surgical follow-up, according to a study in the November issue of Archives of Otolaryngology–Head & Neck Surgery.
Advanced visualization developer EDDA Technology (Booth 9318) is showcasing its IQQA-Liver application at the 2009 Radiological Society of North America (RSNA) conference in Chicago later this month.
The use of fractionated stereotactic radiotherapy (FSR) on patients with optic nerve sheath meningiomas results in less vision loss than when patients are treated with conventional surgery, based on a study presented today at the annual meeting of the American Society for Radiation Oncology in Chicago.
Ion Beam Applications (IBA) has introduced Proteus Nano, a two-room proton therapy solution at the annual meeting of the American Society for Radiology Oncology (ASTRO) in Chicago this week.
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.